Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group (Q82533907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

6

Sang Dal Rhee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

14

Jin Hee Ahn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093259

31 August 2024

author name string

Sung Wook Kwon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Seung Kyu Kang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jae Hong Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Joo Hwan Bok

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Chi Hyun Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Won Hoon Jung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hee Youn Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Myung Ae Bae

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jin Sook Song

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Duck Chan Ha

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hyae Gyoung Cheon

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ki Young Kim

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21093259

31 August 2024

publication date

2 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 January 2020

https://api.elsevier.com/content/article/PII:S0960894X10015842?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

https://api.elsevier.com/content/article/PII:S0960894X10015842?httpAccept=text/plain

31 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Bioorganic & Medicinal Chemistry Letters

31 August 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

435-439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

11 beta-hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily

16 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

The Journal of Clinical Endocrinology and Metabolism

31 August 2024

2

87

877

Kataoka

2002

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

A transgenic model of visceral obesity and the metabolic syndrome

31 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice

31 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

31 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

31 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development

31 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221).

31 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

31 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors

31 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design

31 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.

31 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.

31 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.10.123

31 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093259%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference